Table 1 Subject characteristics
Characteristic | |
|---|---|
Age: mean (SD) [range] | 35.1 (10.8) [18, 62] |
Female Sex: n (%) | 40 (53.3) |
delF508 Homozygous: n (%) | 44 (59) |
CF related diabetes: n (%) | 32 (43.2) |
ABPA (allergic bronchopulmonary aspergillosis): n (%) | 6 (8.3) |
Asthma: n (%) | 60 (82.3) |
Aspergillus Fumigatus sensitization (IgE > 0.35 Ku/L): n (%) | 17 (23.0) |
Any fungal sensitization (IgE > 0.35 Ku/L): n (%) | 9 (12.0) |
Fungal presence: n (%) | |
Aspergillus spp. | 51 (69.9) |
Exophiala, or Rasamsonia or Scedosporium (ERS) | 23 (31.5) |
Bacterial presence: n (%) | |
Pseudomonas | 51 (69.9) |
MRSA | 24 (32.9) |
Achromobacter spp. or Stenotrophomonas spp. | 22 (30.1) |
Mycobacteria | 15 (20.8) |
Exacerbations: n (%) | |
0 Exacerbations per year | 15(20.2) |
1–2 Exacerbations per year | 42 (57.5) |
> 2 Exacerbations per year | 17 (23.3) |
Medications: n (%) | |
CFTR modulators | 51 (69.9) |
Inhaled corticosteroids | 51 (69.9) |